Abstract
Background:Cerebral vasospasm leading to delayed ischemia is a common and serious complication of aneurysmal subarachnoid hemorrhage that often results in increased morbidity and mortality. Treatments for cerebral vasospasm, including triple-H therapy (therapeutic hypervolemia, hypertension, and hemodilution), nimodipine, balloon angioplasty, and intra-arterial vasodilators have limitations in their efficacy and safety profiles. Nicardipine, a calcium channel blocker, is available for intravenous administration for blood pressure reduction. A recent study reported its efficacy in the treatment of cerebral vasospasm when given intrathecally (IT). We present our experiences with IT nicardipine for treatment of cerebral vasospasm.Methods:IT nicardipine was administered to six patients with aneurysmal subarachnoid hemorrhage after prophylactic and aggressive therapeutic management for vasospasm failed.Results:In these patients, IT nicardipine treatment was followed within 8 hours by a 43.1 ± 31.0 cm/s decrease in middle cerebral arterial flow velocity, as measured by transcranial Doppler ultrasound.Conclusions:Based on these positive results, we believe that larger scale studies evaluating the safety and efficacy of IT nicardipine for the management of cerebral vasospasm are warranted.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Biller J, Godersky JC, Adams HP Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke 1988;19:1300–1305.BillerJ]]GoderskyJC]]AdamsHPJrManagement of aneurysmal subarachnoid hemorrhage.Stroke1988191300-13052. Barker FG II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 1996;84:405–414.BarkerFGII]]OgilvyCSEfficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis.J Neurosurg199684405-4143. Lee K, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care 2006;4:68–76.LeeK]]LukovitsT]]FriedmanJA“Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage.Neurocrit Care2006468-764. Dorhout Mees SM, Rinkel GJE, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;3:CD000277.Dorhout MeesSM]]RinkelGJE]]FeiginVL&etal;Calcium antagonists for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev20073CD0002775. Wong GK, Chan MT, Poon WS, et al. Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea. Neurol Res 2006;28:431–435.WongGK]]ChanMT]]PoonWS&etal;Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.Neurol Res200628431-4356. Tseng M, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627–1632.TsengM]]CzosnykaM]]RichardsH&etal;Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial.Stroke2005361627-16327. Kramer AH, Gurka MJ, Nathan B, et al. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 2008;62:422–427; discussion 427–430.8. Kasuya H, Onda H, Takeshita M, et al. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002;33:1011–1015.KasuyaH]]OndaH]]TakeshitaM&etal;Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans.Stroke2002331011-10159. Suzuki M, Doi M, Otawara Y, et al. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 2001;24:180–184.SuzukiM]]DoiM]]OtawaraY&etal;Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage.Neurosurg Rev200124180-18410. Shibuya M, Suzuki Y, Enomoto H, et al. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1994;131:19–25.ShibuyaM]]SuzukiY]]EnomotoH&etal;Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.Acta Neurochir (Wien)199413119-2511. Seifert V, Löffler B, Zimmermann M, et al. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 1995;82:55–62.SeifertV]]LöfflerB]]ZimmermannM&etal;Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma.J Neurosurg19958255-6212. Ehrenreich H, Lange M, Near KA, et al. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 1992;192:257–268.EhrenreichH]]LangeM]]NearKA&etal;Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage.Res Exp Med (Berl)1992192257-26813. Tegeler CH, Babikian VL, Gomez CR (eds). Neurosonology. St. Louis, MO, Mosby, 1996.&NA;Tegeler CH, Babikian VL, Gomez CRNeurosonology.St. Louis, MOMosby199614. Lysakowski C, Walder B, Costanza MC, et al. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 2001;32:2292–2298.LysakowskiC]]WalderB]]CostanzaMC&etal;Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review.Stroke2001322292-229815. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke 1999;30:317–320.CloftHJ]]JosephGJ]]DionJERisk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis.Stroke199930317-32016. Dawkins AA, Evans AL, Wattam J, et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology 2007;49:753–759.DawkinsAA]]EvansAL]]WattamJ&etal;Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures.Neuroradiology200749753-75917. Ameriso SF, Paganini-Hill A, Meiselman HJ, et al. Correlates of middle cerebral artery blood velocity in the elderly. Stroke 1990;21:1579–1583.AmerisoSF]]Paganini-HillA]]MeiselmanHJ&etal;Correlates of middle cerebral artery blood velocity in the elderly.Stroke1990211579-1583
